Hyaphilia is a modern type of filler, used in cosmetology practice to combat a number of aesthetic problems. It has a progressive composition, a high degree of purification, and a minimum number of contraindications. You can correct wrinkles or change the shape of your lips with this drug in our injection cosmetology clinic “BL”.
What's happened
Hyafilia fillers are drugs produced by a well-known Korean company. The product is produced in the form of a gel with a plastic and thick consistency. A distinctive feature of such agents is their ability to diffuse within the space requiring correction, as well as to prevent premature natural destruction of cellular structures.
As a rule, this effect is caused by the components that make up the gels. The preparations contain 85% hyaluronic acid arranged in the form of a chain, 15% native hyaluron with free molecules, which is modified using Pendant technology.
Korean-made fillers are usually cheaper than their counterparts from the USA and Europe.
But not all of them are certified in Russia. Therefore, you need to make sure that the drug has successfully passed all tests and can be used in the country.
Cosmetologist, dermatovenerologist, laser therapist.
Nachoeva Irina Nasredinovna
7 years experience
Hyafilia preparations with hyaluronic acid.
About the product Hyafilia fillers with hyaluronic acid, Korea
HyaFilia fillers with hyaluronic acid, SHA MedtechCo. Ltd. (South Korea)
HyaFilia preparations are 5th generation fillers of a hybrid structure. They combined the best qualities of both mono- and biphasic products.
Compliance of the quality and safety of drugs with international and Ukrainian standards has been proven by clinical trials and officially confirmed by relevant certificates.
CERTIFIED IN UKRAINE
The biphasic structure of the gel is a combination of biotechnological stabilized hyaluronic acid 85% and an unstabilized fraction of 15%. The latest technology and composition provide the filler with high plasticity during injection. Filler implantation gives a quick and long-lasting effect not only due to volumization, but also by improving the quality of the skin. The duration of the aesthetic effect is 6 – 14 months. HyaFilia preparations biodegrade to water and carbon dioxide (H2O and CO2) and are completely eliminated from the body. This ensures safety for the patient during the re-correction procedure, and also allows the specialist to achieve a better result.
During natural biodegradation, fragmentation and migration of the drug in tissues does not occur, which is ensured by its high degree of thixotropy. The drug is resistant to free radicals, which protects it from premature breakdown. The gel has a memory of a given shape, which is retained after its administration. This distinguishes HyaFilia from monophasic drugs. This property guarantees an excellent correction effect and the appearance of the patient.
The duration of the effect depends individually on age, the somatic state of the body, its own enzyme activity, lifestyle and the characteristics of the drug.
HyaFilia is a new generation of fillers based on hyaluronic acid . Their main distinguishing feature is the simultaneous combination of the advantages of monophasic and biphasic drugs. HyaFilia is recommended for the correction and smoothing of pronounced wrinkles, folds and post-acne scars, by injecting it directly into the dermis or subcutaneous tissue.
For more detailed information, please contact us by contact numbers.
Laboratory of the company SNA MedtechCo. Ltd. specializes in the development and production of biphasic fillers based on hyaluronic acid of non-animal origin. High quality products and innovative developments have led to continuously growing demand from partners around the world.
The full line of Hyafilia fillers allows for complete correction of wrinkles, folds, and also replenish tissue volume.
The HyaFilia filler production technology includes a process for stabilizing hyaluronic acid. This is due to the fact that the biodegradation of native HA in a living organism occurs very quickly, and its reticulation with the help of a stabilizer can significantly increase the time of HA cleavage by hyaluronidase. HyaFilia fillers, produced using CHAMedtechCo.Ltd. technology, are stabilized with butanediol diglycidyl ether (BDDE).
HyaFilia filler production technology allows the production of drugs with various properties to correct various aesthetic problems. The different uses of HyaFilia preparations depend on the size of the reticulated hyaluronic acid particles and the degree of their cross-linking. HyaFilia Petit contains particles with the smallest size and the lowest degree of reticulation. HyaFilia filler contains particles with an average size and an average degree of reticulation. And the drug HyaFilia Grand has the largest particle size and a high degree of reticulation.
Characteristics of HyaFilia hyaluronic acid fillers
The HyaFilia line of fillers based on hyaluronic acid is characterized by a combination of effectiveness in correcting cosmetic imperfections, optimal plasticity during injection and deployment in tissues, complete biodegradation to water and carbon dioxide, absence of a toxic component and minimal allergenicity.
Biphasic in nature, Hyafilia fillers allow for targeted and precise facial correction. Due to the addition of unstabilized hyaluronic acid, the preparations have sufficient plasticity, like monophasic fillers, which facilitates their distribution in tissues. A high modulus of elasticity and a low modulus of fluidity guarantee the maintenance of the effect (duration of stay in tissues is 9-12 months). The natural, highly purified hyaluronic acid included in the fillers harmoniously corrects age-related defects in the skin of the face, neck, décolleté, hands, prolonging natural beauty and youth for a long time skin.
Hyaluronic acid included in HyaFilia fillers
Origin : obtained by bacterial fermentation of an artificial strain of streptococci (Streptococcus equi), non-pathogenic to humans.
Advantages:
- Non-species specific;
- biocompatible, non-immunogenic;
- non-animal origin (does not require allergy tests before the procedure);
- biodegradable;
- stable after administration;
- minimal residual hygroscopicity;
- cross-linked with BDDE.
FILLER with hyaluronic acid “HYAFILIA PETIT”
Hyafilia Petit – used to correct fine and superficial wrinkles. Concentration : 20 mg/ml Volumetric capacity : +++ Indications : 1. correction of the nasolacrimal groove 2. fine wrinkle lines 3. “crow’s feet” 4. perioral lines 5. linear wrinkles in the area between the eyebrows 6. correction of lip contours Guaranteed duration of action : 9 months. Injection level : deep layer of the dermis.
FILLER with hyaluronic acid “HYAFILIA”
Hyafilia – used to correct moderate wrinkles and increase lip volume. Concentration: 20 mg/ml Volume capacity: ++++ Indications: 1. filling of wrinkles of medium depth 2. correction of nasolabial folds 3. “marionette lines” 4. increasing lip volume 5. perioral wrinkles 6. correction of hands Guaranteed duration of action: 9 months. Injection level: subdermal.
FILLER with hyaluronic acid “HYAFILIA GRAND”
Hyafilia Grand is the densest filler in the series for increasing the volume of the cheekbones, chin, and cheeks. Concentration : 20 mg/ml Volume capacity : +++++ Indications : 1. volumetric remodeling 2. enlargement of cheekbones, chin, temporal area 3. correction of the bridge of the nose Guaranteed duration of action : up to 12 months. Injection level : supraperiosteal, deep subdermal.
Benefits of HyaFilia products
• The high degree of cross-linking means that the length of the polymer chains between the BDDE ester bonds is quite short. This significantly complicates the biodegradation of the filler by hyaluronidase and is clinically manifested by an increase in the duration of the aesthetic effect. Compared to other biphasic fillers, the degree of cross-linking of HyaFilia preparations is the highest - over 6 mol/%.
•A high concentration of reticulated hyaluronic acid ensures a sufficient duration of biodegradation of the filler, and accordingly increases the duration of the corrective effect. Usually the total concentration of HA is indicated - both stabilized and native. But native HA in a biphasic filler biodegrades quite quickly and its amount does not affect the duration of the filler effect. In HyaFilia preparations, the concentration of total HA is 20%, the concentration of cross-linked HA is 17%, this is the maximum concentration for modern biphasic fillers.
• The optimal ratio of viscosity and elasticity of HyaFilia preparations, with high plasticity, allows you to achieve the most predictable result. In HyaFilia Petit filler, designed to correct the least pronounced wrinkles, viscosity (55.5 Pa) and elasticity (295 Pa) are minimal. With low viscosity (71.6 Pa) and fairly high elasticity (357.8 Pa), HyaFilia is designed to correct moderate changes. HyaFilia Grand has the highest viscosity (164.6 Pa) and elasticity (472.2 Pa) and is used to correct the deepest wrinkles and folds.
• The minimal amount of residual protein in HyaFilia preparations, compared with other HA-based fillers, allows minimizing the risk of allergic reactions.
• The ratio of the gel and liquid phases in fillers based on HA determines such properties of the filler as the plasticity of the drug, the severity and duration of the effect. HyaFilia preparations are much more flexible than monophasic preparations due to the presence of a liquid component (15%). At the same time, the amount of reticulated HA (85%) is noticeably greater than that of similar biphasic preparations, which increases the biodegradation period of HyaFilia fillers. The liquid component of the preparations consists not only of native HA, but also of modified non-reticulated HA, which also prolongs the corrective effect of fillers.
• The absence of free (residual) BDDE in HyaFilia fillers has been convincingly proven by chromatography of the preparations. HyaFilia chromatography diagrams show no evidence of BDDE. This indicates that all BDDE is associated with HA and HyaFilia fillers do not have a toxic load on the patient’s body.
• The minimum content of endotoxins in HyaFilia preparations (less than 0.25 EU/ml) also indicates the high safety of the preparations.
• The high degree of swelling (4 ml/g) makes HyaFilia more effective than other biphasic fillers.
• The osmolarity of HyaFilia preparations is as close as possible to the osmolarity of the interstitial fluid of a healthy body (300 mOsm/kg). Accordingly, the administration of HyaFilia is more easily tolerated by the patient and is less likely to show signs of inflammation (redness and swelling) than the administration of similar fillers.
Manufacturer: SNA MedtechCo. Ltd. specializes in the development and production of bio-pharmaceuticals (cell therapy drugs, biological dosage forms and drugs based on recombinant protein), as well as cosmetics based on hyaluronic acid - the main raw material of bio-cosmetic products.
Founded in August 2013 by SNA MedtechCo. Ltd., is a division of CHA Bio & Diostech, engaged in the sale and production of medical devices and pharmaceutical products.
SNA MedtechCo. Ltd. develops and produces various growth factors and growth hormone preparations. The company conducts ongoing research in this direction, developing raw materials for the production of pharmaceutical products, as well as for growing and differentiating stem cell cultures.
SNA MeditechCo. Ltd. not only supplies raw materials for production, but also produces, supplies and improves growth factor preparations necessary for improving skin quality, in joint cooperation with LG Household & Healthcare.
In addition, the company develops and supplies medical products based on hyaluronic acid.
Compliance of production resources SNA MeditechCo. Ltd. GMP and ISO standards, confirmation of product quality with KFDA and CE certificates and the presence of highly qualified personnel have allowed the company to become one of the leading manufacturers of pharmaceutical and medical products. This is confirmed by the company’s constant success in the biomedical industry, manifested in the continuous expansion and development of the line of bio-products.
MAIN ADVANTAGES OVER FAMOUS COMPETITORS:
• The high degree of cross-linking means that the length of the polymer chains between the BDDE ester bonds is quite short. This significantly complicates the biodegradation of the filler by hyaluronidase and is clinically manifested by an increase in the duration of the aesthetic effect. Compared to other biphasic fillers, the degree of cross-linking of HyaFilia preparations is the highest - over 6 mol/%.
• A high concentration of reticulated hyaluronic acid ensures a sufficient duration of biodegradation of the filler, and accordingly increases the duration of the corrective effect. Usually the total concentration of HA is indicated - both stabilized and native. But native HA in a biphasic filler biodegrades quite quickly and its amount does not affect the duration of the filler effect. In HyaFilia preparations, the concentration of total HA is 20%, the concentration of cross-linked HA is 17%, this is the maximum concentration for modern biphasic fillers.
• The optimal ratio of viscosity and elasticity of HyaFilia preparations , with high plasticity, allows you to achieve the most predictable result. In HyaFilia Petit filler, designed to correct the least pronounced wrinkles, viscosity (55.5 Pa) and elasticity (295 Pa) are minimal. With low viscosity (71.6 Pa) and fairly high elasticity (357.8 Pa), HyaFilia is designed to correct moderate changes. HyaFilia Grand has the highest viscosity (164.6 Pa) and elasticity (472.2 Pa) and is used to correct the deepest wrinkles and folds.
• The minimum amount of residual protein in HyaFilia preparations , compared with other HA-based fillers, allows us to minimize the risk of developing allergic reactions.
• The ratio of the gel and liquid phases in fillers based on HA determines such properties of the filler as the plasticity of the drug, the severity and duration of the effect. HyaFilia preparations are much more flexible than monophasic preparations due to the presence of a liquid component (15%). At the same time, the amount of reticulated HA (85%) is noticeably greater than that of similar biphasic preparations, which increases the biodegradation period of HyaFilia fillers. The liquid component of the preparations consists not only of native HA, but also of modified non-reticulated HA, which also prolongs the corrective effect of fillers.
• No free (residual) BDDE in HyaFilia fillers
How are they different from others?
The products of the HyaFilia line are represented by fifth-generation fillers with a hybrid structure. The cosmetics combine all the best qualities of biphasic and monophasic products.
Lip augmentation with Juvederm
Juvederm® (Yuvederm®) is a new trend in the cosmetic industry.
The main difference from other similar drugs is that they simultaneously combine all the advantages of mono- and biphasic drugs.
HyaFilia gels can solve most cosmetic defects, including those associated with age-related changes.
Description and composition of the drug
Hyafilia filler is a fairly thick and flexible gel that can fill the corrected subcutaneous space as evenly as possible. A distinctive property of the drug is its high resistance to premature resorption (helps to maintain the positive result of correction for as long as possible).
Hyafilia preparations are fifth-generation fillers with a hybrid structure (the best characteristics of mono and biphasic products are combined).
The main component is natural, highly purified hyaluronic acid, which gently, without disturbing the natural lines, corrects age-related and aesthetic changes in the skin of the face, neck, hands, and preserves the natural beauty and youth of the skin for as long as possible.
Kinds
The Hyafilia series products include several types of products, which contain hyaluronic acid in a single concentration - 20 mg/ml.
It is worth noting that the consistency of the gels may differ from each other. Such characteristics are usually influenced by the molecular size of the active substance, as well as the density of their connection with each other. As a result, the area of use for each product will also be different.
Petit
This type of drug is the lightest in the presented line of products. It is used to treat the surface layers of the epidermis. The composition contains small particles of hyaluron, which are stitched together with minimal density.
It is used to eliminate mild wrinkles in the perioral area, on the forehead and in the area between the eyebrows. It also helps remove crow's feet and allows you to correct the lip contour.
Classic
The molecules are of medium size and have a moderate degree of reticulation. Due to this, it is possible to achieve a more pronounced result, in contrast to the use of the means described above.
The drug must be administered at the subdermal epithelial level. It helps smooth out moderate and deep wrinkles, increase lip volume, and eliminate age-related changes on the hands.
Grand
It differs from previous products by higher viscosity and elasticity. Designed for introduction into the deep layers of the dermis, as well as into the periosteum area.
It is used for contour plastic surgery when it is necessary to correct convex parts - the nose, cheekbones or chin.
Plus
Any of the above-described cosmetic products can be marked with this mark. They have the same composition. However, in this case it will be supplemented with lidocaine. This allows the procedure to be carried out with minimal discomfort and less severe pain.
HyaFilia fillers
The Optimus Center for Aesthetics and Health presents HyaFilia - a new generation of fillers based on hyaluronic acid. Their main distinguishing feature is the simultaneous combination of the advantages of monophasic and biphasic drugs. HyaFilia is recommended for the correction and smoothing of pronounced wrinkles, folds and post-acne scars, by injecting it directly into the dermis or subcutaneous tissue.
The manufacturer is SNA Medtech Co. Ltd. (South Korea). It specializes in the development and production of biopharmaceuticals (cell therapy drugs, biological dosage forms and recombinant protein-based drugs), as well as cosmetics based on hyaluronic acid - the main raw material of bio-cosmetic products.
Compliance of production resources SNA MeditechCo. Ltd. GMP and ISO standards, confirmation of product quality with KFDA and CE certificates and the presence of highly qualified personnel have allowed the company to become one of the leading manufacturers of pharmaceutical and medical products. This is confirmed by the company’s constant success in the biomedical industry, manifested in the continuous expansion and development of the line of bioproducts.
Technology
HyaFilia filler production technology includes a process for stabilizing hyaluronic acid. This is due to the fact that the biodegradation of native HA in a living organism occurs very quickly, and reticulation with the help of a stabilizer can significantly increase the time of HA cleavage by hyaluronidase. HyaFilia fillers produced using CHAMedtechCo.Ltd technology. , are stabilized with butanediol diglycidyl ether (BDDE).
As a result of the interaction of HA and BDDE, a biphasic gel is formed containing:
At the same time, BDDE reacted completely, without a trace!
The sufficiently high content of reticulated hyaluronic acid in HyaFilia fillers ensures a significant duration of the volumizing effect of the drugs. At the same time, the relatively large volume of the liquid component gives HyaFilia fillers optimal plasticity. The liquid phase consists of native and modified forms of hyaluronic acid. HyaFilia fillers contain hyaluronic acid modified using MedtechCo CHA technology. Ltd. and having a pendant-type structure, in which one end of the BDDE molecule is tightly bound to the hyaluronic acid chain, and the other is in a free state. The acid modified in this way successfully resists biodegradation by hyaluronidase, and, at the same time, as a liquid component of the preparations, increases their plasticity.
HyaFilia filler production technology allows the production of drugs with various properties to correct various aesthetic problems. The different uses of HyaFilia preparations depend on the size of the reticulated hyaluronic acid particles and the degree of their cross-linking. HyaFilia Petit HyaFilia filler contains particles with an average size and an average degree of reticulation. And the drug HyaFilia Grand has the largest particle size and a high degree of reticulation.
HyaFilia products for patients has been proven by animal tests conducted in November 2009 in Korea: at the Medical Device Evaluation Center, at the Clinical Research Institute and at Seoul National University Hospital. The effectiveness of the drugs was proven during efficacy tests on mice at the Department of Plastic Surgery, Korea University College of Medicine (April, 2010). Multiple clinical studies in leading clinics in South Korea (CHA University Bundang CHA Hospital, Korea University Guro Hospital, Catholic University Seoul St. Mary's Hospital) confirmed these results in solving specific aesthetic problems.
HyaFilia preparations
The line includes 3 drugs: HyaFiliaPetit , HyaFilia and HyaFiliaGrand , which are intended for the correction of aesthetic changes of varying severity and differ from each other in the size of HA particles and the degree of reticulation.
HyaFiliaPetit is designed for the correction of fine and superficial wrinkles, and is the most flexible in the line. Injected into the superficial layers of the dermis. Available in 1 ml syringes with 27G and 29G needles and 2 and 3 ml syringes with 25G and 27G needles.
HyaFilia filler is used to correct wrinkles of moderate severity; its plasticity corresponds to the most common correction indications. The depth of injection is the middle layers of the dermis. Available in 1 ml syringes with 27G and 29G needles and 2 and 3 ml syringes with 25G and 27G needles.
The use of HyaFiliaGrand is indicated for the correction of deep wrinkles and pronounced folds, to create volume during involutive changes in the pancreas. This drug is the densest in the line, has maximum reticulation and the size of HA particles is 1100 microns. Injected into the deep layers of the dermis and subcutaneous tissue. Available in 1 ml syringes with 23G and 27G needles and 2 and 3 ml syringes with 23G and 27G needles.
HyaFilia drugs belong to the Ⅲ safety class and, as a medical product, have CE and KFDA certificates. The safety and effectiveness of HyaFilia has been proven by animal tests and multiple clinical studies in leading clinics in South Korea.
Application
Benefits of HyaFilia products
• The high degree of cross-linking means that the length of the polymer chains between the BDDE ester bonds is quite short. This significantly complicates the biodegradation of the filler by hyaluronidase and is clinically manifested in an increase in the duration of the aesthetic effect. Compared to other biphasic fillers, the degree of cross-linking of HyaFilia is the highest - over 6 mol/%.
• A high concentration of reticulated hyaluronic acid ensures a sufficient duration of biodegradation of the filler, and accordingly increases the duration of the corrective effect. Usually the total concentration of HA is indicated - both stabilized and native. But native HA in a biphasic filler biodegrades quickly enough and its amount does not affect the duration of the filler effect. HyaFilia preparations , with a concentration of total HA of 20%, the concentration of cross-linked HA is 17%, this is the maximum concentration for modern biphasic fillers.
• The optimal ratio of viscosity and elasticity of HyaFilia , with high plasticity, allows you to achieve the most predictable result. In HyaFilia Petit filler, intended for the correction of the least pronounced wrinkles, viscosity (55.5 Pa) and elasticity (295 Pa) are minimal. With low viscosity (71.6 Pa) and fairly high elasticity (357.8 Pa), HyaFilia is designed to correct moderate changes. HyaFilia Grand has the highest viscosity (164.6 Pa) and elasticity (472.2 Pa) and is used to correct the deepest wrinkles and folds.
• The minimum amount of residual protein in HyaFilia , compared with other HA-based fillers, minimizes the risk of allergic reactions.
• The ratio of the gel and liquid phases in fillers based on HA determines such properties of the filler as the plasticity of the drug, the severity and duration of the effect. HyaFilia preparations are much more flexible than monophasic preparations due to the presence of a liquid component (15%). At the same time, the amount of reticulated HA (85%) is noticeably greater than that of similar biphasic preparations, which increases the biodegradation period of HyaFilia fillers. The liquid component of the preparations consists not only of native HA, but also of modified non-reticulated HA, which also prolongs the corrective effect of fillers.
• The absence of free (residual) BDDE in HyaFilia has been convincingly proven by chromatography of the preparations. HyaFilia chromatography diagrams show no evidence of BDDE. This indicates that all BDDE is associated with HA and HyaFilia do not have a toxic load on the patient’s body.
• The minimum content of endotoxins in HyaFilia (less than 0.25 EU/ml) also indicates the high safety of the preparations.
• The high degree of swelling (4 ml/g) makes HyaFilia than other biphasic fillers.
• The osmolarity of HyaFilia is as close as possible to the osmolarity of the interstitial fluid of a healthy body (300 mOsm/kg). Accordingly, the administration of HyaFilia is more easily tolerated by the patient and is less likely to show signs of inflammation (redness and swelling) than the administration of similar fillers.
Make an appointment with a specialist or ask questions that interest you
You can call:
+7 (391) 2-347-340 Krasnoyarsk, st. Extreme, 2A +7 Krasnoyarsk, st. Kopylova, 70
THERE ARE CONTRAINDICATIONS. CONSULT A PROFESSIONAL.
Indications
Fillers from the HyaFilia series are used in the presence of problems such as increased dryness of the skin, which may be caused by age-related transformation of the epidermis, sagging, the formation of deep wrinkles, as well as furrows in the area of the nasolabial folds.
Why can our articles be trusted?
We make health information clear, accessible and relevant.
- All articles are checked by practicing doctors.
- We take scientific literature and the latest research as a basis.
- We publish detailed articles that answer all questions.
In addition, the indications include the need to correct and model the oval of the face, as well as some of its parts, for example, lips, nose, temporal zone or cheeks.
Contraindications
Non-surgical contouring using HyaFilia products has its certain limitations.
Thus, drugs in this series are prohibited for use in cases of cancer, autoimmune and somatic pathologies, diabetes mellitus, endocrine disorders, and individual intolerance to components.
In addition, contraindications include blood diseases, blood clotting disorders, chronic pathologies at the acute stage, the presence of inflammatory processes in the area requiring treatment, the menstrual cycle, and dermatological problems.
The procedure is also prohibited during pregnancy and breastfeeding.
Neglecting the listed conditions can lead to unpredictable consequences.
Contraindications and side effects
A mandatory procedure that a qualified cosmetologist must carry out before the filler injection procedure is an examination and collection of the patient’s medical history. The specialist must be sure that the client has no contraindications that could cause severe complications and undesirable consequences.
The patient, in turn, is also obliged to clearly and timely provide reliable information about the condition of his body, recent diseases or drug treatment.
Contraindications to contouring using Hiaphilia fillers are:
- previously diagnosed autoimmune and somatic diseases;
- oncopathology;
- diseases of the circulatory system;
- endocrine diseases and diabetes;
- skin diseases;
- inflammatory processes;
- individual intolerance to any of the components of the drug;
- viral diseases in the acute phase of development.
It is prohibited to carry out correction by introducing fillers if the patient is undergoing rehabilitation after surgery, is carrying a child, or is breastfeeding a baby.
Ignoring contraindications for correction, as well as mistakes made by a cosmetologist during the process of introducing fillers, can lead to the development of the following side effects:
- severe allergic reactions with severe itching, redness and inflammation of the skin;
- tissue necrosis at the site of filler injection;
- the appearance of hematomas, granulomas and skin compactions;
- severe swelling and pain in the treated area of the facial skin.
Attention: at the slightest manifestation of a negative reaction, you must immediately consult a doctor for help.
Stages of execution by a cosmetologist
If you have decided to carry out the procedure using HyaFilia gels, then you must contact only trusted clinics and entrust the work to highly qualified specialists. Only an experienced doctor knows how to work with such products to achieve maximum results.
Fillers do not require special preparation. It will be enough to open the package just before use and connect a suitable tip to the syringe.
Before making injections, the cosmetologist must thoroughly clean the surface of the skin from decorative cosmetics, fatty secretions and other contaminants. After this, the epidermis is treated with an antiseptic solution.
If necessary, an anesthetic may be applied to the skin. This manipulation is carried out at the request of the client.
If a drug containing lidocaine is used, then additional anesthesia is not necessary.
The filler is administered according to a pre-selected method. The principle of action can be based on the task assigned to the cosmetologist. As a rule, the doctor chooses a cannula or a thin needle to work with.
The selected surface is chipped with gel using a specific technique. In this case, it is necessary to ensure that the substance is evenly distributed under the layers of the epidermis. It is worth noting that the use of a cannula can significantly reduce soft tissue injury.
Depending on which filler will be used during the cosmetic procedure, its quantity and injection depth will be selected individually in each case.
After all the above steps have been completed, the cosmetologist performs a light massage of the treatment area, which also helps to distribute the drug evenly.
At the final stage, antiseptic treatment is repeated.
In general, the duration of the procedure is from 20 minutes to one and a half hours.
Recommendations after
As a rule, HyaFilia fillers do not require a recovery period. Within two hours the patient can return to his normal lifestyle. However, in order to get the desired result and reduce the risks of complications, experts recommend adhering to certain rules for further skin care.
On the first day, do not touch the treated surface with your hands. You should not carry out any cosmetic procedures or come into contact with running water.
In addition, for several days it is important to monitor facial expressions - do not smile or express any emotions.
For four days after the session, you must refrain from playing sports and any other physical activity. Increased sweating can cause complications such as infection or inflammation.
Also prohibited is visiting a bathhouse, sauna, tanning in a solarium or in direct sunlight.
Consequences
Side effects are rare after using HyaFilia products. This often happens due to the fault of a specialist when the filler injection technology was violated, or due to the fault of a patient who ignored recommendations in the post-procedure period.
Among the most common complications are the development of skin necrosis, inflammatory processes, allergies accompanied by itching, irritation and redness, the formation of hematomas, granulomas, the appearance of pronounced swelling, and severe pain at the injection site.
Benefits of the drugs
- Instant and long-lasting effect. The results of therapy are noticeable almost immediately after using the drugs. According to user reviews, the gels last up to 14 months. The shelf life of therapy results may be shorter, depending on the area of administration, the characteristics of the patient’s body and lifestyle, and the complexity of aesthetic defects.
- No side effects. Fillers do not contain free binding agents; hyaluronic acid is similar in properties to that produced by the human body. Due to this, the likelihood of side effects and rejection is minimized.
- Ease of use. The drugs are quite flexible and it is convenient for the doctor to work with them. The gels are easily distributed in the skin, the likelihood of formation of clots and nodules is minimal.
- Predictable result. The gels hold their shape well and can be used for complex contouring: lip augmentation, correction of facial contours, and cheekbone lifting.
Advantages and disadvantages
If we compare the HyaFilia series fillers with other similar drugs, they have a longer lasting effect that lasts up to nine months or more. In addition, Korean gels have higher plasticity, which ensures maximum removal of the product from the body.
The advantages also include low cost, ease of use, and minimal side effects.
Among the disadvantages are the presence of contraindications.
HyaFilia fillers are a worthy alternative to drugs from European manufacturers. Their distinctive feature is their affordable cost, safety and hypoallergenicity. Before using the products, consultation with a specialist is required.
What is the main difference between this type of filler?
HyaFilia biodegradable fillers have a special hybrid structure. It combines fractions of stabilized and unstabilized hyaluronic acid in a ratio of 85/15. Before cross-linking, the molecules of hyaluronic acid are divided by size - thanks to this, the finished product has high plasticity, quickly gains volume in the tissues and retains it for a long time (more than a year).
The hybrid filler does not migrate or fragment during gradual biodegradation (this distinguishes it from popular biphasic fillers). The product is resistant to free radicals - this provides protection against premature volume loss.
Another advantage is the complete biodegradation of the filler.
The drug is absolutely safe and has a Registration Certificate from Roszdravnadzor (RU). The drug is completely biodegradable and is gradually eliminated from the body by the lymphatic system.
It is important that the severity of the correction remains stable even in patients with active facial expressions and fast metabolism.
Effect 6-14 months Discomfort 1 of 5 Anesthesia Application Rehabilitation None
Discuss the procedure with a specialist
Leave your phone number. We will call you back!
